Axitinib Impurity M |
|
| Synonyms: N1(indazolyl)-Methyl Axitinib;N-Methyl-2-[[3-[(1E)-2-(pyridinyl) ethenyl]-[N-methyl,1H-indazol-6-yl-thiol]]-benzamide. | |
| Cat. No.: A86013 | CAS No.: Parent: 319460-85-0 |
| MDL.: | Formula: C23H20N4OS |
| F.W.400.50 | Purity: 99% |
| Storage: | |
|   | |
| Catalog Number: | A86013 | CAS No.: | Parent: 319460-85-0 | |
| MDL: | Formula: | C23H20N4OS | ||
| F.W.: | 400.50 | Purity: | 99% | |
| Package: | Unit: | |||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Reference: | Wasser, K., et al.: Eur. Radiol., 13, 80 (2003), Park, J., et al.: Clin. Cancer Res., 8, 1172 (2002), Bergers, G., et al.: J. Clin. Invest., 111, 1287 (2003), | |||
| Application: | N-Methyl-2-[[3-[(1E)-2-(pyridinyl) ethenyl]-[N-methyl,1H-indazol-6-yl-thiol]]-benzamide (N-methyl axitinib) is an impurity of axitinib, a tyrosine kinase inhibitor and is used in cancer therapy. | |||
| Category: | Aromatics, Impurities & Metabolites, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, | |||








